Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 5;21(1):5.
doi: 10.1186/s12888-020-03006-z.

Genetic susceptibility of opioid receptor genes polymorphism to drug addiction: A candidate-gene association study

Laith N Al-Eitan  1   2 , Doaa M Rababa'h  3 , Mansour A Alghamdi  4   5
Affiliations

Genetic susceptibility of opioid receptor genes polymorphism to drug addiction: A candidate-gene association study

Laith N Al-Eitan et al. BMC Psychiatry. .

Abstract

Background: Like other complex diseases including drug addiction, genetic factors can interfere with the disease. In this study, three opioid genes (OPRM1, OPRD1, and OPRK1) were examined for an association with drug addiction among Jordanian males.

Methods: The study involved 498 addicts, in addition to 496 healthy controls and all from Arab descent.

Results: The findings in this study showed that rs1799971 of the OPRM1 gene was in association with drug addiction for both alleles and genotypes with P-values = 0.002 and 0.01, respectively. In addition, a significant association between the dominant model (A/A vs G/A-G/G) of rs1799971 (OPRM1) and drug addiction (P-value = 0.003, OR = 1.59 (1.17-2.15)) was detected. Moreover, a genetic haplotype (AGGGCGACCCC) of theOPRM1 gene revealed a significant association with drug addiction (P-value = 0.01, OR = 1.56 (1.15-2.12)). We also found that the age of addicts, smoking, and marital status with genetic variants within OPRM1, OPRD1, and OPRK1 genes may be implicated in drug addiction risk.

Conclusion: We propose that rs1799971 of the OPRM1gene is a genetic risk factor for drug addiction among Jordanian males.

Keywords: Drug addiction; Jordan; Opioids; Polymorphism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Ahmed M, UlHaq I, Faisal M, Waseem D, Taqi MM. Implication of OPRM1 A118G polymorphism in opioids addicts in Pakistan: in vitro and Insilico analysis. J Mol Neurosci. 2018;65:472. doi: 10.1007/s12031-018-1123-1. - DOI - PMC - PubMed
    1. Jadidi N, Nakhaee N. Etiology of drug abuse: a narrative analysis. J Addict. 2014;2014:352835. doi: 10.1155/2014/352835. - DOI - PMC - PubMed
    1. Al-Eitan LN, Jaradat SA, Hulse GK, Tay GK. Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Rese Notes. 2012;5:497. doi: 10.1186/1756-0500-5-497. - DOI - PMC - PubMed
    1. AL-Eitan L, Tarkhan A. Practical challenges and translational issues in pharmacogenomics and personalized medicine from 2010 onwards. Curr Pharmacogenom Personalized Med. 2016;14:7–17. doi: 10.2174/1875692115666161215103842. - DOI
    1. Al-Eitan LN, Jaradt SA, Hulse GK, Tay GK. Pharmacogenetic approach to treating drug dependence: serotonin transporter gene (SLC6A4) promoter polymorphisms as treatment predictors in Jordanian Arabs. Curr Pharmacogenomics Pers Med. 2012;10:293–305. doi: 10.2174/187569212803901783. - DOI

Publication types

MeSH terms